Study of Letrozole With or Without BYL719 or Buparlisib, for the Neoadjuvant Treatment of Postmenopausal Women
Clinical trial NCT01923168 · COMPLETED
Trial details
- NCT number
- NCT01923168
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-11
- Primary completion
- 2017-07-07
- Enrollment
- 340
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.